XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock and additional paid-in capital
Retained earnings/(Accumulated deficit)
Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 24, 2022 $ 50,672 $ 64,849 $ (3,068) $ (11,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock withheld related to net share settlement of equity awards   (1,434) (978)  
Share-based compensation   2,984    
Net income 29,998   29,998  
Dividends and dividend equivalents declared     (3,712)  
Common stock repurchased     (19,000)  
Other comprehensive income/(loss) (1,803)     (1,803)
Ending balances at Dec. 31, 2022 $ 56,727 66,399 3,240 (12,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.23      
Beginning balances at Sep. 30, 2023 $ 62,146 73,812 (214) (11,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock withheld related to net share settlement of equity awards   (1,660) (1,018)  
Share-based compensation   3,084    
Net income 33,916   33,916  
Dividends and dividend equivalents declared     (3,774)  
Common stock repurchased (20,500)   (20,668)  
Other comprehensive income/(loss) 2,074     2,074
Ending balances at Dec. 30, 2023 $ 74,100 $ 75,236 $ 8,242 $ (9,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.24